| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.3 | +169.6% | |
| Cost of revenue | 0.0 | 0.0 | 0.3 | 0.5 | 0.4 | 0.8 | +108.5% | |
| Gross profit | 0.0 | 0.0 | (0.3) | (0.3) | (0.3) | (0.5) | −79.3% | |
| Research & development | — | — | — | — | 0.1 | 0.1 | −4.1% | |
| Operating expenses | 0.0 | 0.3 | 2.6 | 3.0 | 4.2 | 5.3 | +25.8% | |
| Operating income | (0.0) | (0.3) | (2.9) | (3.3) | (4.5) | (5.7) | −28.8% | |
| Interest expense | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | −72.4% | |
| Interest income | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | −86.3% | |
| Pre-tax income | (0.0) | (0.3) | (3.7) | (3.8) | (3.7) | (5.8) | −56.8% | |
| Income tax | 0.0 | 0.0 | 0.0 | (0.0) | (0.1) | (0.1) | +35.7% | |
| Net income | (0.0) | (0.3) | (3.7) | (3.8) | (3.6) | (5.8) | −60.2% | |
| EPS, basic (per share) | (0.01) | (0.01) | (0.03) | (0.01) | (0.01) | (0.02) | −45.6% | |
| EPS, diluted (per share) | (0.01) | (0.01) | (0.03) | (0.01) | (0.01) | (0.02) | −45.6% | |
| EBITDA | (0.0) | (0.3) | (2.6) | (3.1) | (4.2) | (5.4) | −30.2% | |
| Depreciation & amortization | — | 0.0 | 0.3 | 0.3 | 0.3 | 0.3 | +9.6% | |
| Weighted average shares (shares) | 1,649,902 | — | 114,001,831 | 297,641,507 | 348,843,233 | 382,706,417 | +9.7% | |
| Weighted average diluted shares (shares) | 1,649,902 | — | 114,001,831 | 297,641,507 | 348,843,233 | 382,706,417 | +9.7% | |
| Gross margin | — | — | −7,267.7% | −121.7% | −209.6% | −139.3% | +70.2 pts | |
| Operating margin | — | — | −74,048.6% | −1,456.2% | −3,629.9% | −1,734.9% | +1895.1 pts | |
| Net margin | — | — | −95,998.0% | −1,645.7% | −2,931.6% | −1,742.0% | +1189.6 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
